Insider Transactions in Q3 2021 at Inari Medical, Inc. (NARI)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 27
2021
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-3.16%
|
$410,000
$82.92 P/Share
|
|
Sep 27
2021
|
Thomas Tu Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+8.5%
|
$0
$0.46 P/Share
|
|
Sep 17
2021
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
9,000
-2.55%
|
$720,000
$80.89 P/Share
|
|
Sep 10
2021
|
Donald B Milder Director |
SELL
Open market or private sale
|
Indirect |
7,000
-0.05%
|
$567,000
$81.1 P/Share
|
|
Sep 09
2021
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-1.82%
|
$410,000
$82.09 P/Share
|
|
Sep 09
2021
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+5.1%
|
$0
$0.46 P/Share
|
|
Sep 07
2021
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
30,000
-1.39%
|
$2,430,000
$81.41 P/Share
|
|
Aug 27
2021
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-3.2%
|
$405,000
$81.47 P/Share
|
|
Aug 27
2021
|
Thomas Tu Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+8.5%
|
$0
$0.46 P/Share
|
|
Aug 19
2021
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
9,000
-2.43%
|
$648,000
$72.79 P/Share
|
|
Aug 18
2021
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+18.53%
|
$0
$0.46 P/Share
|
|
Aug 18
2021
|
Andrew Hykes President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+9.17%
|
$0
$0.43 P/Share
|
|
Aug 10
2021
|
Donald B Milder Director |
SELL
Open market or private sale
|
Indirect |
7,000
-0.03%
|
$637,000
$91.99 P/Share
|
|
Aug 09
2021
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-2.33%
|
$475,000
$95.06 P/Share
|
|
Aug 09
2021
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+6.43%
|
$0
$0.46 P/Share
|
|
Aug 05
2021
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
30,000
-1.33%
|
$2,790,000
$93.21 P/Share
|
|
Jul 27
2021
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-2.4%
|
$420,000
$84.51 P/Share
|
|
Jul 27
2021
|
Thomas Tu Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+8.5%
|
$0
$0.46 P/Share
|
|
Jul 19
2021
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
9,000
-1.16%
|
$765,000
$85.28 P/Share
|
|
Jul 09
2021
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-1.76%
|
$460,000
$92.3 P/Share
|
|
Jul 09
2021
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+6.43%
|
$0
$0.46 P/Share
|
|
Jul 09
2021
|
Donald B Milder Director |
SELL
Open market or private sale
|
Indirect |
7,000
-0.04%
|
$644,000
$92.27 P/Share
|
|
Jul 07
2021
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
69,915
-1.44%
|
$6,432,180
$92.26 P/Share
|
|
Jul 06
2021
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
60,085
-1.38%
|
$5,647,990
$94.18 P/Share
|
|
Jul 06
2021
|
William Hoffman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
462
-0.06%
|
$43,890
$95.99 P/Share
|
|
Jul 06
2021
|
Hill, Mitch C. Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
231
-0.34%
|
$21,945
$95.99 P/Share
|
|
Jul 06
2021
|
Thomas Tu Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
240
-0.49%
|
$22,800
$95.99 P/Share
|
|
Jul 06
2021
|
Andrew Hykes President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
347
-0.18%
|
$32,965
$95.99 P/Share
|